From hepatocytes to stem and progenitor cells for liver regenerative medicine: Advances and clinical perspectives

Cell Proliferation

Volumn 44, Issue SUPPL. 1, 2011, Pages 39-43

  Sokal, E M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CELL; CRYOPRESERVATION; HEMATOPOIETIC CELL; HEPATOCYTE TRANSPLANTATION; HUMAN; INBORN ERROR OF METABOLISM; LIVER CELL; LIVER PARENCHYMA; LIVER REGENERATION; MESENCHYMAL STEM CELL; NONHUMAN; REGENERATIVE MEDICINE; STEM CELL;

ANIMALS; BONE MARROW TRANSPLANTATION; HEPATOCYTES; HUMANS; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION;

EID: 79953882451     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00730.x     Document Type: Article

References (47)

1. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI et al. (1998) Treatment of the crigler-najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338, 1422-1426.
2. Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R et al. (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76, 735-738.
3. Smets F, Najimi M, Sokal EM (2008) Cell transplantation in the treatment of liver diseases. Pediatr. Transplant. 12, 6-13.
4. Nussler A, Konig S, Ott M, Sokal E, Christ B, Thasler W et al. (2006) Present status and perspectives of cell-based therapies for liver diseases. J. Hepatol. 45, 144-159.
5. Lysy PA, Najimi M, Stephenne X, Bourgois A, Smets F, Sokal EM (2008) Liver cell transplantation for crigler-najjar syndrome type I: update and perspectives. World J. Gastroenterol. 14, 3464-3470.
6. Stéphenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM (2005) Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am. J. Transplant. 5, 2058-2061.
7. Stéphenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM (2006) Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130, 1317-1323.
8. Meyburg J, Das AM, Hoerster F, Lindner M, Kriegbaum H, Engelmann G et al. (2009) One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation 87, 636-641.
9. Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P et al. (2002) Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359, 317-318.
10. Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S et al. (2004) Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78, 1812-1814.
11. Stéphenne X, Vosters O, Najimi M, Beuneu C, Dung KN, Wijns W et al. (2007) Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl. 13, 599-606.
12. Stéphenne X, Najimi M, Ngoc DK, Smets F, Hue L, Guigas B et al. (2007) Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transplant. 16, 409-419.
13. Meyburg J, Hoerster F, Schmidt J, Poeschl J, Hoffmann GF, Schenk JP (2010) Monitoring of intraportal liver cell application in children. Cell Transplant. 19, 629-638.
14. Sancho-Bru P, Najimi M, Caruso M, Pauwelyn K, Cantz T, Forbes S et al. (2009) Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut 58, 594-603.
15. Stéphenne X, Najimi M, Sokal EM (2010) Hepatocyte cryopreservation: is it time to change the strategy? World J. Gastroenterol. 16, 1-14.
16. Baldo G, Giugliani R, Uribe C, Belardinelli MC, Duarte ME, Meurer L et al. (2010) Bone marrow mononuclear cell transplantation improves survival and induces hepatocyte proliferation in rats after ccl(4) acute liver damage. Dig. Dis. Sci., 55, 3384-3392.
17. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M et al. (2003) Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422, 897-901.
18. Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabeva MD et al. (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 112, 160-169.
19. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L et al. (2000) Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 6, 1229-1234.
20. Mallet VO, Mitchell C, Mezey E, Fabre M, Guidotti JE, Renia L et al. (2002) Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology 35, 799-804.
21. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM et al. (2000) Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 31, 235-240.
22. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC et al. (2008) Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134, 2111-2121.
23. Ehnert S, Nussler AK, Lehmann A, Dooley S (2008) Blood monocyte-derived neohepatocytes as in vitro test system for drug metabolism. Drug Metab. Dispos. 36, 1922-1929.
24. Ruhnke M, Nussler AK, Ungefroren H, Hengstler JG, Kremer B, Hoeckh W et al. (2005) Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 79, 1097-1103.
25. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247.
26. Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM (2007) Human skin fibroblasts: from mesodermal to hepatocyte-like differentiation. Hepatology 46, 1574-1585.
27. Lysy PA, Campard D, Smets F, Malaise J, Mourad M, Najimi M et al. (2008) Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells. Cell Prolif. 41, 36-58.
28. Marongiu F, Gramignoli R, Sun Q, Tahan V, Miki T, Dorko K et al. (2010) Isolation of amniotic mesenchymal stem cells. Curr. Protoc. Stem Cell. Biol. Chapter 1:Unit 1E.5.
29. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH et al. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40, 1275-1284.
30. Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH et al. (2006) In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells 24, 1759-1768.
31. Campard D, Lysy PA, Najimi M, Sokal EM (2008) Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134, 833-848.
32. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M et al. (2005) Mesenchymal stem cells derived from cd133-positive cells in mobilized peripheral blood and cord blood: proliferation, oct4 expression, and plasticity. Stem Cells 23, 1105-1112.
33. Snykers S, De Kock J, Rogiers V, Vanhaecke T (2009) In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells 27, 577-605.
34. Zemel R, Bachmetov L, Ad-El D, Abraham A, Tur-Kaspa R (2009) Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells. Liver Int. 29, 1326-1337.
35. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G et al. (2007) Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46, 219-228.
36. Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T et al. (2009) Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 58, 570-581.
37. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
38. Shi XL, Zhang Y, Gu JY, Ding YT (2009) Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions. Transplantation 88, 1178-1185.
39. Fausto N, Campbell JS (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120, 117-130.
40. Zhang W, Chen XP, Zhang WG, Zhang F, Xiang S, Dong HH et al. (2009) Hepatic non-parenchymal cells and extracellular matrix participate in oval cell-mediated liver regeneration. World J. Gastroenterol. 15, 552-560.
41. Chen L, Chen XP, Zhang W, Liang HF, Lin YZ, Dong HH et al. (2009) Differentiation of hepatic oval cell into mature hepatocyte induced by hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 17, 765-770.
42. Khuu DN, Najimi M, Sokal EM (2007) Epithelial cells with hepatobiliary phenotype: is it another stem cell candidate for healthy adult human liver? World J. Gastroenterol. 13, 1554-1560.
43. Mitaka T (1998) The current status of primary hepatocyte culture. Int. J. Exp. Pathol. 79, 393-409.
44. Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sempoux C et al. (2007) Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes? Cell Transplant. 16, 717-728.
45. Khuu N, Scheers I, Ehnert S, Jazouli N, Nyabi O, Buc-Calderon P et al. (2010) In vitro differentiated adult human liver progenitor cells display mature hepatic metabolic functions: a potential tool for in vitro pharmaco-toxicological testing. Cell Transplant. Aug 17. [Epub ahead of print].
46. Roelants V, Labar D, de Meester C, Havaux X, Tabilio A, Gambhir SS et al. (2008) Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells. J. Nucl. Med. 49, 1836-1844.
47. Bohnen NI, Charron M, Reyes J, Rubinstein W, Strom SC, Swanson D et al. (2000) Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin. Nucl. Med. 25, 447-450.